IRIS
MALAPELLE, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.858
NA - Nord America 9.413
EU - Europa 7.788
SA - Sud America 1.471
AF - Africa 274
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 10
Totale 32.830
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.992
SG - Singapore 6.233
RU - Federazione Russa 3.508
CN - Cina 2.691
IT - Italia 1.964
VN - Vietnam 1.959
HK - Hong Kong 1.281
BR - Brasile 1.174
DE - Germania 497
FR - Francia 450
IN - India 369
NL - Olanda 272
JP - Giappone 248
BD - Bangladesh 243
KR - Corea 226
GB - Regno Unito 224
CA - Canada 215
FI - Finlandia 209
MX - Messico 127
AR - Argentina 124
ES - Italia 122
IE - Irlanda 109
IQ - Iraq 78
PH - Filippine 75
UA - Ucraina 74
PL - Polonia 64
TH - Thailandia 59
ZA - Sudafrica 58
EC - Ecuador 54
ID - Indonesia 54
SE - Svezia 51
PK - Pakistan 49
AT - Austria 46
CI - Costa d'Avorio 45
TR - Turchia 44
VE - Venezuela 30
EG - Egitto 29
GR - Grecia 27
LT - Lituania 27
TW - Taiwan 27
UZ - Uzbekistan 26
CO - Colombia 24
MA - Marocco 24
JO - Giordania 22
KE - Kenya 22
SA - Arabia Saudita 19
TN - Tunisia 19
IR - Iran 18
BE - Belgio 17
PY - Paraguay 17
CH - Svizzera 16
IL - Israele 16
NP - Nepal 16
PE - Perù 15
RO - Romania 15
CR - Costa Rica 12
DZ - Algeria 12
RS - Serbia 12
MY - Malesia 11
SY - Repubblica araba siriana 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
BO - Bolivia 10
CL - Cile 10
JM - Giamaica 10
AL - Albania 9
AU - Australia 9
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
UY - Uruguay 9
PT - Portogallo 8
TT - Trinidad e Tobago 8
ET - Etiopia 7
HU - Ungheria 7
NG - Nigeria 7
OM - Oman 7
PA - Panama 7
PS - Palestinian Territory 7
DO - Repubblica Dominicana 6
GE - Georgia 6
HN - Honduras 6
KZ - Kazakistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
GA - Gabon 5
LB - Libano 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
DK - Danimarca 4
HR - Croazia 4
KG - Kirghizistan 4
KW - Kuwait 4
LV - Lettonia 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
TZ - Tanzania 4
UG - Uganda 4
BH - Bahrain 3
BN - Brunei Darussalam 3
BS - Bahamas 3
BW - Botswana 3
Totale 32.723
Salva come PNG Salva come JPEG
Città #
Singapore 3.021
San Jose 1.861
Hong Kong 1.237
Hefei 996
Moscow 890
Ashburn 879
Chandler 684
Beijing 562
Ho Chi Minh City 557
Hanoi 439
Naples 349
Lauterbourg 339
The Dalles 300
Santa Clara 295
Los Angeles 275
Tokyo 211
Millbury 199
Milan 190
Seoul 190
Munich 173
Buffalo 164
Kochi 164
New York 160
Amsterdam 158
Redondo Beach 149
Lawrence 145
Dallas 132
Des Moines 130
Napoli 123
Boston 120
São Paulo 117
Rome 109
Haiphong 102
Helsinki 84
Nanjing 78
Princeton 75
Council Bluffs 74
Da Nang 73
Wilmington 70
Orem 68
Mexico City 66
Frankfurt am Main 65
Valencia 61
Seattle 53
Chicago 52
Warsaw 49
Boardman 48
Toronto 47
Montreal 46
Atlanta 45
Ottawa 45
Nuremberg 44
Brooklyn 41
Chennai 41
Turku 41
Denver 39
Biên Hòa 38
Falkenstein 37
Rio de Janeiro 36
London 35
Stockholm 31
Hải Dương 30
Phoenix 30
Houston 29
Bologna 27
Dublin 27
Fairfield 27
Nanchang 27
Baghdad 25
Can Tho 25
Johannesburg 25
Poplar 25
Turin 25
Guangzhou 24
Manchester 23
Tashkent 22
Amman 21
Lappeenranta 21
Bangkok 20
Belo Horizonte 20
Florence 20
Jacksonville 20
New Delhi 20
Thái Nguyên 20
Guayaquil 19
Nairobi 19
Redwood City 19
San Francisco 19
Curitiba 18
Memphis 18
Shanghai 18
Kronberg 17
Tianjin 17
Ankara 16
Bari 16
Cairo 16
Düsseldorf 16
Hebei 16
Philadelphia 16
Salt Lake City 16
Totale 17.731
Salva come PNG Salva come JPEG
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 223
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 193
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 188
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 167
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 166
Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens 164
The Cause of Death of a Child in the 18th Century Solved by Bone Microbiome Typing Using Laser Microdissection and Next Generation Sequencing 164
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 162
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 162
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 157
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 156
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 155
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 154
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 154
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 154
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 152
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 152
CBX7 is a tumor suppressor in mice and humans. 152
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 150
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 150
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 148
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 148
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 147
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 147
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 147
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 146
miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene 144
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 144
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 143
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 139
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 138
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 137
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 137
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 136
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer 136
Endoscopic ultrsound-guided fine needle aspiration (EUS-FNA) in lymph nodal and mediastinal lesions : a multicenter experience 135
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 135
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 135
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 135
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 133
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 133
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment 133
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 133
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 133
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 132
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 132
Next generation sequencing in cytology 131
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type 130
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 130
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 130
Role of Cytomorphology in the Era of Liquid Biopsy 130
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 130
Antitumor efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models. 129
Predictive molecular pathology in the time of COVID-19 129
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) 128
Evaluation of a fully closed real time PCR platform for the detection of SARS-CoV-2 in nasopharyngeal swabs: a pilot study 128
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
The role of liquid biopsy in epithelial ovarian cancer: state of the art 127
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 127
Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients With Cancer: A Narrative Review 126
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 126
EGFR mutation detection by microfluidic technology: a validation study. 125
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 125
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 125
The evolving role of liquid biopsy in lung cancer 124
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 124
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 124
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 124
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 123
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 123
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 122
Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study 121
Brca1/2 ngs somatic testing in clinical practice: a short report 121
UbcH10 overexpression is less pronounced in older colorectal cancer patients 120
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 120
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 120
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 119
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 119
Tumor mutational burden on cytological samples: A pilot study 119
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 119
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 118
Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine-needle aspirates suspicious for Hurthle cell neoplasms. 118
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 118
Osimertinib 118
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer 118
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 118
BRAF: A Two-Faced Janus 118
Light chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto thyroiditis. 117
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 117
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 117
BRAF mutations in lung cancer 117
EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing 117
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 117
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 116
Innovation in next-generation sequencing in non-Small cell lung cancer diagnostics 116
Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm 116
Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 116
PD-L1 and beyond: Immuno-oncology in cytopathology 116
Applications and limitations of oncogene mutation testing in clinical cytopathology. 115
Totale 13.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.298
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/20221.162 33 15 24 16 13 23 15 101 105 118 246 453
2022/20231.795 248 87 67 125 230 200 8 202 292 162 143 31
2023/20241.466 62 225 146 64 62 98 56 171 48 77 276 181
2024/20258.808 462 554 45 70 190 328 912 527 739 1.097 3.027 857
2025/202618.798 1.916 1.885 1.918 1.664 2.881 792 1.960 1.353 2.270 1.142 665 352
Totale 33.431